Trocoxil 20 mg Chewable Tablets for Dogs

Pays: Royaume-Uni

Langue: anglais

Source: VMD (Veterinary Medicines Directorate)

Ingrédients actifs:

Mavacoxib

Disponible depuis:

Zoetis UK Limited

Code ATC:

QM01AH92

DCI (Dénomination commune internationale):

Mavacoxib

forme pharmaceutique:

Chewable tablet

Type d'ordonnance:

POM-V - Prescription Only Medicine – Veterinarian

Groupe thérapeutique:

Dogs

Domaine thérapeutique:

Anti Inflammatory NSAID

Statut de autorisation:

Authorized

Date de l'autorisation:

2008-09-09

Résumé des caractéristiques du produit

Issued: October 2023
AN: 01444/2022
Page 1 of 8
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Trocoxil 20 mg chewable tablets for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains:
ACTIVE SUBSTANCE:
Mavacoxib
20 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablets
Triangular tablet with mottled brown appearance embossed with the
tablet strength
on one side, the reverse side is blank.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs aged 12 months or more.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of pain and inflammation associated with
degenerative joint
disease in dogs in cases where continuous treatment exceeding one
month is
indicated.
4.3
CONTRAINDICATIONS
Do not use in dogs less than 12 months of age and/or less than 5 kg
body weight.
Do not use in dogs suffering from gastro-intestinal disorders
including ulceration
and bleeding.
Do not use where there is evidence of a haemorrhagic disorder.
Do not use in cases of impaired renal or hepatic function.
Do not use in cases of cardiac insufficiency.
Issued: October 2023
AN: 01444/2022
Page 2 of 8
Do not use in pregnant, breeding or lactating dogs.
Do not use in cases of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in case of known hypersensitivity to sulphonamides.
Do not use concomitantly with glucocorticoids or other Non-Steroidal
Anti-
Inflammatory Drugs (NSAIDs), see section 4.8.
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as
there is a
potential risk of increased renal toxicity.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Do not administer other NSAIDs or glucocorticoids concurrently or
within 1 month of
the last administration of Trocoxil.
4.5
SPECIAL PRECAUTIONS FOR USE
i.
Special precautions for use in animals
Mavacoxib exhibits an extended plasma half life (up to > 80 days, see
section 5.2)
due to its low rate of elimination. This corresponds to a duration of
effect